Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 6
◽
pp. S9
Keyword(s):
Keyword(s):
2019 ◽
Vol 82
(9)
◽
pp. 693-698
◽
Keyword(s):